Feasibility of Study of Empagliflozin in Patients With Autosomal Dominant Polycystic Kidney Disease

NCT05510115 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Polycystic Kidney, Autosomal Dominant

Interventions

DRUG: Empagliflozin
DRUG: Placebo

Sponsor

University of Colorado, Denver

Collaborators

[object Object]
[object Object]